Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox resubmits AC-170 (ZERVIATE1) NDA to the U.S. FDA

March 9, 2017

View Press Release Corporate presentation Contact us
Previous